BioAge Labs (BIOA) Share-based Compensation (2023 - 2025)

BioAge Labs (BIOA) has 3 years of Share-based Compensation data on file, last reported at $2.7 million in Q4 2025.

• For the quarter ending Q4 2025, Share-based Compensation changed 0.04% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $9.1 million (down 1.91% YoY), and the FY2025 full-year result was $23.8 million, down 9.85% from the prior year.
• Share-based Compensation eased to $2.7 million in Q4 2025, from $26.9 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $26.9 million in Q3 2025 to a low of $282000.0 in Q1 2024.
• A 3-year average of $4.8 million and a median of $2.7 million in 2024 frame the typical range for Share-based Compensation.
• Peak annual rise in Share-based Compensation reached 1355.63% in 2025, while the deepest fall reached 0.04% in 2025.
• Tracing BIOA's Share-based Compensation over 3 years: stood at $757000.0 in 2023, then soared by 259.45% to $2.7 million in 2024, then gained by 0.04% to $2.7 million in 2025.
• Business Quant data shows BIOA's Share-based Compensation at $2.7 million in Q4 2025, $26.9 million in Q3 2025, and $3.2 million in Q2 2025.